VIDEO: Improved diagnosing, screening for multiple myeloma . Varshavsky-Yanovsky reports serving on advisory boards for Bristol Myers Squibb and Janssen; and consulting for Pfizer.

Multiple myeloma and race: Find out how disparities can affect diagnosis, treatment, and outcomes. Skip to main content . ... The PROMISE study, which is focused on early screening, ...

"We don't routinely screen for multiple myeloma, but I think it's now recognized that certain populations are at increased ...

"Myeloma symptoms are nonspecific, and therefore, a long diagnostic pathway is likely to continue if we rely upon health care workers to think of the diagnosis before a myeloma screen is performed ...

Multiple myeloma accounts for about 10% of all hematological cancers and carries an estimated average lifetime risk of less than 1%. ... "We don't routinely screen for multiple myeloma, ...

Screening tests are not perfect and have some risks. The screening programme should also be good value for money for the NHS. What to do if you think you're at risk of myeloma. Talk to your GP if you ...

Is there screening for smoldering multiple myeloma? There are no screening recommendations for SMM, so it is usually diagnosed by accident. As abnormal plasma cells accumulate, they release ...

Multiple myeloma is a form of blood cancer that affects the plasma cells. In some cases, plasma cells gradually decline and cause a condition called hypogammaglobulinemia. Medical News Today ...

Multiple myeloma or its treatments can make these issues worse. If you notice eye problems, let your local Department of Motor Vehicles (DMV) know. You may need to retake your vision screening ...

High-risk smoldering multiple myeloma (SMM) has emerged as the condition where treatment yields the greatest benefit, said S. Vincent Rajkumar, MD, professor of medicine at Mayo Clinic.